FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289202007> ?p ?o ?g. }

• W4289202007 endingPage "713" @default.
• W4289202007 startingPage "705" @default.
• W4289202007 abstract "Knowledge of the adverse effects of drugs with anticholinergic properties (DAPs) has increased in recent decades. However, research on the temporal trends of the clinical use of DAPs is still sparse. The aim of this study was to investigate the temporal trends of DAP use over two decades in the older community-dwelling population and to explore the medication classes contributing to the use of DAPs. The study involved random samples of ≥ 75-year-old community-dwelling Helsinki citizens in 1999, 2009, and 2019 from the Helsinki Ageing Study. A postal questionnaire inquired about their health, functioning, and medications. The medications were categorized as DAPs according to Duran’s list. In addition, we grouped DAPs into various medication groups. The prevalence and burden of DAPs on Duran's list showed a decreasing trend over the years. In 1999 the prevalence was 20% and the burden 0.35, in 2009 they were 22% and 0.35, respectively, and in 2019 they were 16% and 0.23, respectively. There were no differences in how the 75- and 80-year-olds used DAPs compared with those aged 85 years and older. The proportion of typical antipsychotics, benzodiazepines, hypnotics, urinary antispasmodics, and asthma/chronic obstructive pulmonary disease medications decreased, whereas the proportion of atypical antipsychotics, antidepressants, strong opioids, and antihistamines increased. In particular the use of mirtazapine increased—to 3.9% in 2019. In 2019 the three most prevalent groups of DAPs were antidepressants (7.4%), opioids (2.7%), and antihistamines (2.4%). The decrease in the use of DAPs on Duran's list is a welcome change. Although the use of old, strong DAPs has decreased, new DAPs have simultaneously emerged. Physicians need continuous education in prescribing DAPs and more recent information on the use and effects of DAPs is needed in order to decrease their exposure among the rapidly growing older population." @default.
• W4289202007 created "2022-08-01" @default.
• W4289202007 creator A5017001187 @default.
• W4289202007 creator A5027525816 @default.
• W4289202007 creator A5030022003 @default.
• W4289202007 creator A5034594046 @default.
• W4289202007 creator A5039377744 @default.
• W4289202007 creator A5053824930 @default.
• W4289202007 creator A5054241200 @default.
• W4289202007 creator A5081340205 @default.
• W4289202007 date "2022-08-01" @default.
• W4289202007 modified "2023-10-11" @default.
• W4289202007 title "Temporal Trends Over Two Decades in the Use of Anticholinergic Drugs Among Older Community-Dwelling People in Helsinki, Finland" @default.
• W4289202007 cites W1984458220 @default.
• W4289202007 cites W2000445173 @default.
• W4289202007 cites W2070961119 @default.
• W4289202007 cites W2095755860 @default.
• W4289202007 cites W2124171898 @default.
• W4289202007 cites W2129571441 @default.
• W4289202007 cites W2130997146 @default.
• W4289202007 cites W2139337687 @default.
• W4289202007 cites W2139560403 @default.
• W4289202007 cites W2147584980 @default.
• W4289202007 cites W2162173660 @default.
• W4289202007 cites W2170684277 @default.
• W4289202007 cites W2172525040 @default.
• W4289202007 cites W2741630474 @default.
• W4289202007 cites W2742415368 @default.
• W4289202007 cites W2790657788 @default.
• W4289202007 cites W2794676581 @default.
• W4289202007 cites W2809843788 @default.
• W4289202007 cites W2912907121 @default.
• W4289202007 cites W2988719897 @default.
• W4289202007 cites W3044462762 @default.
• W4289202007 cites W3049580569 @default.
• W4289202007 cites W4210913656 @default.
• W4289202007 doi "https://doi.org/10.1007/s40266-022-00968-5" @default.
• W4289202007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35913553" @default.
• W4289202007 hasPublicationYear "2022" @default.
• W4289202007 type Work @default.
• W4289202007 citedByCount "2" @default.
• W4289202007 countsByYear W42892020072023 @default.
• W4289202007 crossrefType "journal-article" @default.
• W4289202007 hasAuthorship W4289202007A5017001187 @default.
• W4289202007 hasAuthorship W4289202007A5027525816 @default.
• W4289202007 hasAuthorship W4289202007A5030022003 @default.
• W4289202007 hasAuthorship W4289202007A5034594046 @default.
• W4289202007 hasAuthorship W4289202007A5039377744 @default.
• W4289202007 hasAuthorship W4289202007A5053824930 @default.
• W4289202007 hasAuthorship W4289202007A5054241200 @default.
• W4289202007 hasAuthorship W4289202007A5081340205 @default.
• W4289202007 hasBestOaLocation W42892020071 @default.
• W4289202007 hasConcept C118552586 @default.
• W4289202007 hasConcept C126322002 @default.
• W4289202007 hasConcept C197934379 @default.
• W4289202007 hasConcept C23276603 @default.
• W4289202007 hasConcept C2426938 @default.
• W4289202007 hasConcept C2778689640 @default.
• W4289202007 hasConcept C2779177272 @default.
• W4289202007 hasConcept C2781068410 @default.
• W4289202007 hasConcept C2908647359 @default.
• W4289202007 hasConcept C500440147 @default.
• W4289202007 hasConcept C558461103 @default.
• W4289202007 hasConcept C71924100 @default.
• W4289202007 hasConcept C74909509 @default.
• W4289202007 hasConcept C98274493 @default.
• W4289202007 hasConcept C99454951 @default.
• W4289202007 hasConceptScore W4289202007C118552586 @default.
• W4289202007 hasConceptScore W4289202007C126322002 @default.
• W4289202007 hasConceptScore W4289202007C197934379 @default.
• W4289202007 hasConceptScore W4289202007C23276603 @default.
• W4289202007 hasConceptScore W4289202007C2426938 @default.
• W4289202007 hasConceptScore W4289202007C2778689640 @default.
• W4289202007 hasConceptScore W4289202007C2779177272 @default.
• W4289202007 hasConceptScore W4289202007C2781068410 @default.
• W4289202007 hasConceptScore W4289202007C2908647359 @default.
• W4289202007 hasConceptScore W4289202007C500440147 @default.
• W4289202007 hasConceptScore W4289202007C558461103 @default.
• W4289202007 hasConceptScore W4289202007C71924100 @default.
• W4289202007 hasConceptScore W4289202007C74909509 @default.
• W4289202007 hasConceptScore W4289202007C98274493 @default.
• W4289202007 hasConceptScore W4289202007C99454951 @default.
• W4289202007 hasFunder F4320322456 @default.
• W4289202007 hasIssue "9" @default.
• W4289202007 hasLocation W42892020071 @default.
• W4289202007 hasLocation W42892020072 @default.
• W4289202007 hasLocation W42892020073 @default.
• W4289202007 hasLocation W42892020074 @default.
• W4289202007 hasLocation W42892020075 @default.
• W4289202007 hasLocation W42892020076 @default.
• W4289202007 hasOpenAccess W4289202007 @default.
• W4289202007 hasPrimaryLocation W42892020071 @default.
• W4289202007 hasRelatedWork W1974416533 @default.
• W4289202007 hasRelatedWork W2051360151 @default.
• W4289202007 hasRelatedWork W2054264801 @default.
• W4289202007 hasRelatedWork W2055421991 @default.
• W4289202007 hasRelatedWork W2060556348 @default.
• W4289202007 hasRelatedWork W2067992333 @default.

• next